合計 50 件の最近のインサイダー取引記録が記録されています PTC Therapeutics, Inc. (PTCT), 内訳は 9 件の買い および 40 件の売り. インサイダー買い総額は $13.96M インサイダー売り総額は $6.06M.
最近活動のある主要インサイダーには Golden Lee Scott, Almstead Neil Gregory, Chutter Jessica Caroline. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — PTCT
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-02 |
Golden Lee Scott |
EVP & Chief Medical Officer |
情報に基づく売り |
829 |
$67.99 |
$56.36K |
79,115 |
| 2026-04-01 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
情報に基づく売り |
80 |
$70.30 |
$5.62K |
60,137 |
| 2026-03-24 |
Chutter Jessica Caroline |
Officer |
不明 |
- |
- |
- |
- |
| 2026-03-24 |
Chutter Jessica Caroline |
Director |
RSU 付与（制限付株式） |
2,896 |
$64.54 |
$186.91K |
2,896 |
| 2026-03-12 |
Klein Matthew B. |
Chief Executive Officer |
情報に基づく売り |
2,662 |
$64.08 |
$170.58K |
396,920 |
| 2026-03-11 |
Klein Matthew B. |
Chief Executive Officer |
RSU 付与（制限付株式） |
12,500 |
- |
- |
399,582 |
| 2026-03-10 |
Okey Stephanie |
Director |
オプション行使（売却） |
14,000 |
$33.63 |
$470.82K |
- |
| 2026-03-05 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
情報に基づく売り |
3,989 |
$63.38 |
$252.82K |
2,737 |
| 2026-03-05 |
Golden Lee Scott |
EVP & Chief Medical Officer |
情報に基づく売り |
10,000 |
$63.38 |
$633.8K |
79,944 |
| 2026-03-05 |
Okey Stephanie |
Director |
情報に基づく売り |
6,333 |
$63.38 |
$401.39K |
8,000 |
| 2026-02-19 |
Boulding Mark Elliott |
Exec. VP and CLO |
情報に基づく売り |
590 |
$69.82 |
$41.19K |
105,212 |
| 2026-02-18 |
Boulding Mark Elliott |
Exec. VP and CLO |
情報に基づく売り |
3,081 |
$69.36 |
$213.7K |
108,231 |
| 2026-02-18 |
Pauwels Eric |
Chief Business Officer |
情報に基づく売り |
3,019 |
$69.36 |
$209.4K |
77,122 |
| 2026-02-18 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
情報に基づく売り |
65 |
$69.36 |
$4.51K |
6,726 |
| 2026-02-18 |
Golden Lee Scott |
EVP & Chief Medical Officer |
情報に基づく売り |
2,484 |
$69.36 |
$172.29K |
89,944 |
| 2026-02-18 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
情報に基づく売り |
2,494 |
$69.36 |
$172.98K |
70,199 |
| 2026-02-18 |
Klein Matthew B. |
Chief Executive Officer |
情報に基づく売り |
7,371 |
$69.36 |
$511.25K |
387,082 |
| 2026-02-18 |
Gravier Pierre |
Chief Financial Officer |
情報に基づく売り |
2,992 |
$69.36 |
$207.53K |
87,318 |
| 2026-02-17 |
Boulding Mark Elliott |
Exec. VP and CLO |
オプション行使（売却） |
2,813 |
$25.69 |
$72.27K |
22,501 |
| 2026-01-12 |
Pauwels Eric |
Chief Business Officer |
情報に基づく売り |
1,024 |
$78.70 |
$80.59K |
80,141 |
| 2026-01-09 |
Pauwels Eric |
Chief Business Officer |
情報に基づく売り |
1,722 |
$77.41 |
$133.3K |
81,165 |
| 2026-01-09 |
Boulding Mark Elliott |
Exec. VP and CLO |
情報に基づく売り |
107 |
$79.52 |
$8.51K |
111,312 |
| 2026-01-08 |
Pauwels Eric |
Chief Business Officer |
情報に基づく売り |
1,454 |
$76.45 |
$111.16K |
82,887 |
| 2026-01-08 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
情報に基づく売り |
59 |
$76.45 |
$4.51K |
6,791 |
| 2026-01-08 |
Boulding Mark Elliott |
Exec. VP and CLO |
情報に基づく売り |
1,286 |
$76.45 |
$98.31K |
113,626 |
| 2026-01-08 |
Golden Lee Scott |
EVP & Chief Medical Officer |
情報に基づく売り |
866 |
$76.45 |
$66.21K |
92,428 |
| 2026-01-08 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
情報に基づく売り |
1,034 |
$76.45 |
$79.05K |
72,693 |
| 2026-01-08 |
Klein Matthew B. |
Chief Executive Officer |
情報に基づく売り |
2,514 |
$76.45 |
$192.2K |
394,453 |
| 2026-01-07 |
Pauwels Eric |
Chief Business Officer |
情報に基づく売り |
1,352 |
$77.48 |
$104.75K |
87,489 |
| 2026-01-07 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
情報に基づく売り |
52 |
$77.48 |
$4.03K |
6,850 |
| 2026-01-07 |
Boulding Mark Elliott |
Exec. VP and CLO |
オプション行使（売却） |
751 |
$38.10 |
$28.61K |
- |
| 2026-01-07 |
Golden Lee Scott |
EVP & Chief Medical Officer |
情報に基づく売り |
642 |
$77.48 |
$49.74K |
93,294 |
| 2026-01-07 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
情報に基づく売り |
1,235 |
$77.45 |
$95.65K |
73,727 |
| 2026-01-07 |
Klein Matthew B. |
Chief Executive Officer |
情報に基づく売り |
3,016 |
$77.48 |
$233.68K |
396,967 |
| 2026-01-06 |
Pauwels Eric |
Chief Business Officer |
情報に基づく売り |
1,789 |
$76.95 |
$137.66K |
88,841 |
| 2026-01-06 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
情報に基づく売り |
54 |
$76.95 |
$4.16K |
6,902 |
| 2026-01-06 |
Boulding Mark Elliott |
Exec. VP and CLO |
情報に基づく売り |
1,739 |
$76.95 |
$133.82K |
119,162 |
| 2026-01-06 |
Golden Lee Scott |
EVP & Chief Medical Officer |
情報に基づく売り |
1,340 |
$76.95 |
$103.11K |
93,936 |
| 2026-01-06 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
情報に基づく売り |
1,381 |
$76.95 |
$106.27K |
74,962 |
| 2026-01-06 |
Klein Matthew B. |
Chief Executive Officer |
情報に基づく売り |
5,149 |
$76.95 |
$396.22K |
399,983 |
| 2026-01-06 |
Gravier Pierre |
Chief Financial Officer |
情報に基づく売り |
2,139 |
$76.95 |
$164.6K |
90,310 |
| 2026-01-05 |
Boulding Mark Elliott |
Exec. VP and CLO |
オプション行使（売却） |
2,266 |
$39.42 |
$89.33K |
9,063 |
| 2026-01-05 |
Reeve Emma |
Director |
オプション行使（売却） |
734 |
$46.54 |
$34.16K |
- |
| 2026-01-02 |
Pauwels Eric |
Chief Business Officer |
RSU 付与（制限付株式） |
50,000 |
$76.74 |
$3.84M |
50,000 |
| 2026-01-02 |
Zeldis Jerome B |
Director |
RSU 付与（制限付株式） |
3,475 |
$76.74 |
$266.67K |
3,475 |
| 2026-01-02 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
RSU 付与（制限付株式） |
520 |
- |
- |
6,956 |
| 2026-01-02 |
Boulding Mark Elliott |
Exec. VP and CLO |
RSU 付与（制限付株式） |
42,500 |
$76.74 |
$3.26M |
42,500 |
| 2026-01-02 |
Reeve Emma |
Director |
RSU 付与（制限付株式） |
3,475 |
$76.74 |
$266.67K |
3,475 |
| 2026-01-02 |
Golden Lee Scott |
EVP & Chief Medical Officer |
RSU 付与（制限付株式） |
46,875 |
$76.74 |
$3.6M |
46,875 |
| 2026-01-02 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
RSU 付与（制限付株式） |
33,125 |
$76.74 |
$2.54M |
33,125 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
